Alexion Pharmaceuticals, Inc. (ALXN) financial statements (2021 and earlier)

Company profile

Business Address 121 SEAPORT BOULEVARD
BOSTON, MA 02210
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,7501,5641,4741,2931,385
Cash and cash equivalents 2,6861,3665849661,010
Short-term investments 64198890327375
Receivables 1,243922727650533
Inventory, net of allowances, customer advances and progress billings 628473460375290
Inventory 628473460375290
Other current assets 456426293260218
Total current assets: 5,0763,3852,9542,5782,425
Noncurrent Assets
Property, plant and equipment 1,1631,4721,3251,036697
Intangible assets, net (including goodwill) 8,3828,6798,9929,3409,756
Goodwill 5,0375,0375,0375,0375,048
Intangible assets, net (excluding goodwill) 3,3443,6413,9544,3034,708
Restricted cash and investments 0    
Other noncurrent assets 429397312299255
Other undisclosed noncurrent assets 2,494    
Total noncurrent assets: 12,46810,54710,62910,67510,708
TOTAL ASSETS: 17,54513,93213,58313,25313,133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 967698710572461
Accounts payable   716457
Accrued liabilities 201171639508403
Employee-related liabilities 191170   
Taxes payable 10424   
Other undisclosed accounts payable and accrued liabilities 471332   
Debt 12794167167175
Restructuring reserve  4   
Business combination, contingent consideration, liability  98 24 
Deferred revenue and credits163721
Contract with customer, liability3
Other liabilities 10134592362
Other undisclosed current liabilities  242   
Total current liabilities: 1,1941,174953823718
Noncurrent Liabilities
Long-term debt and lease obligation 2,3752,5022,7212,8883,281
Long-term debt, excluding current maturities 2,3752,5022,7212,8883,281
Liabilities, other than long-term debt 293173159110626
Deferred tax liabilities, net   529
Liability, pension and other postretirement and postemployment benefits 2818192023
Other liabilities 2661561409073
Other undisclosed noncurrent liabilities 2,410918858738249
Total noncurrent liabilities: 5,0793,5933,7383,7364,156
Total liabilities: 6,2734,7674,6904,5594,875
Stockholders' equity
Stockholders' equity attributable to parent 11,2729,1658,8938,6948,259
Common stock     0
Treasury stock, value (2,106)(1,690)(1,605)(1,141)(711)
Additional paid in capital 8,8058,5398,2907,9577,727
Accumulated other comprehensive income (loss) (67)(10)(34)6062
Retained earnings 4,6402,3262,2421,8181,180
Total stockholders' equity: 11,2729,1658,8938,6948,259
TOTAL LIABILITIES AND EQUITY: 17,54513,93213,58313,25313,133

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 4,9914,1313,5513,0822,603
Revenue, net3,5513,0842,604
Cost of revenue
(Cost of Goods and Services Sold)
 (395)(374)(454)(258)(233)
Gross profit: 4,5973,7573,0972,8242,369
Operating expenses (2,476)(3,487)(2,470)(2,159)(1,834)
Other undisclosed operating income    22
Operating income: 2,120270627667537
Nonoperating income 136711969
Investment income, nonoperating 1006519119
Foreign currency transaction gain (loss), before tax   0(5)1
Other nonoperating income 366   
Interest and debt expense (78)(98)(98)(97)(48)
Income from continuing operations before income taxes: 2,179242548576498
Income tax expense (benefit) 226(165)(105)(177)(354)
Net income available to common stockholders, diluted: 2,40478443399144

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income: 2,40478443399144
Other comprehensive income (loss) 10(7)2 3
Comprehensive income: 2,41571445399147
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (67)32(97)(2)2
Comprehensive income, net of tax, attributable to parent: 2,347102348397150

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: